129 related articles for article (PubMed ID: 1472745)
41. Glomerular basement membrane selective permeability in short-term streptozotocin-induced diabetic rats.
Doucet M; Londoño I; Gómez-Pascual A; Bendayan M
Int J Exp Diabetes Res; 2000; 1(1):19-30. PubMed ID: 11469387
[TBL] [Abstract][Full Text] [Related]
42. Initial ultrastructural changes in pore size and anionic sites of the glomerular basement membrane in streptozotocin-induced diabetic rats and their prevention by insulin treatment.
Isogai S; Mogami K; Shiina N; Yoshino G
Nephron; 1999 Sep; 83(1):53-8. PubMed ID: 10461036
[TBL] [Abstract][Full Text] [Related]
43. Renal injury in streptozotocin-diabetic Ren2-transgenic rats is mainly dependent on hypertension, not on diabetes.
Hartner A; Cordasic N; Klanke B; Wittmann M; Veelken R; Hilgers KF
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F820-7. PubMed ID: 17018847
[TBL] [Abstract][Full Text] [Related]
44. Diabetic glomerulopathy following unilateral nephrectomy in the dog.
Whiteside C; Katz A; Cho C; Silverman M
Clin Invest Med; 1990 Oct; 13(5):279-86. PubMed ID: 1703467
[TBL] [Abstract][Full Text] [Related]
45. Effect of angiotensin II on glomerular structure in streptozotocin-induced diabetic rats.
Nicholas SB; Mauer M; Basgen JM; Aguiniga E; Chon Y
Am J Nephrol; 2004; 24(5):549-56. PubMed ID: 15539791
[TBL] [Abstract][Full Text] [Related]
46. Effect of a low protein diet on the relationship of nonenzymatic glycation to altered renal structure and function in diabetes mellitus.
Copeland KR; Yatscoff RW; Thliveris JA; Penner SB; Mehta A
J Diabet Complications; 1989; 3(2):113-9. PubMed ID: 2526137
[TBL] [Abstract][Full Text] [Related]
47. Renal autoregulation and passive pressure-flow relationships in diabetes and hypertension.
Hill JV; Findon G; Appelhoff RJ; Endre ZH
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F837-44. PubMed ID: 20660017
[TBL] [Abstract][Full Text] [Related]
48. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
[TBL] [Abstract][Full Text] [Related]
49. Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes.
Craven PA; DeRubertis FR; Kagan VE; Melhem M; Studer RK
J Am Soc Nephrol; 1997 Sep; 8(9):1405-14. PubMed ID: 9294832
[TBL] [Abstract][Full Text] [Related]
50. Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats.
Huijberts MS; Wolffenbuttel BH; Crijns FR; Nieuwenhuijzen Kruseman AC; Bemelmans MH; Struijker Boudier HA
Diabetologia; 1994 Jan; 37(1):10-4. PubMed ID: 8150221
[TBL] [Abstract][Full Text] [Related]
51. Myocardial performance of STZ-diabetic DOCA-hypertensive rats.
Dai S; McNeill JH
Am J Physiol; 1992 Dec; 263(6 Pt 2):H1798-805. PubMed ID: 1481903
[TBL] [Abstract][Full Text] [Related]
52. Transient receptor potential cation channel 6 contributes to kidney injury induced by diabetes and hypertension.
Wang Z; Fu Y; do Carmo JM; da Silva AA; Li X; Mouton A; Omoto ACM; Sears J; Hall JE
Am J Physiol Renal Physiol; 2022 Jan; 322(1):F76-F88. PubMed ID: 34866402
[TBL] [Abstract][Full Text] [Related]
53. Thromboxane in the pathogenesis of glomerular injury in diabetes.
Craven PA; Melhem MF; DeRubertis FR
Kidney Int; 1992 Oct; 42(4):937-46. PubMed ID: 1453584
[TBL] [Abstract][Full Text] [Related]
54. Effect of an aldose reductase inhibitor on glomerular basement membrane anionic sites in streptozotocin-induced diabetic rats.
Isogai S; Inokuchi T; Ohe K
Diabetes Res Clin Pract; 1995 Nov; 30(2):111-6. PubMed ID: 8833631
[TBL] [Abstract][Full Text] [Related]
55. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.
Chang WP; Dimitriadis E; Allen T; Dunlop ME; Cooper M; Larkins RG
Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023
[TBL] [Abstract][Full Text] [Related]
56. Diabetic glomerulopathy following unilateral nephrectomy in the rat.
Steffes MW; Brown DM; Mauer SM
Diabetes; 1978 Jan; 27(1):35-41. PubMed ID: 340310
[TBL] [Abstract][Full Text] [Related]
57. Comparison of the effects of levocetirizine and losartan on diabetic nephropathy and vascular dysfunction in streptozotocin-induced diabetic rats.
Anbar HS; Shehatou GS; Suddek GM; Gameil NM
Eur J Pharmacol; 2016 Jun; 780():82-92. PubMed ID: 27012991
[TBL] [Abstract][Full Text] [Related]
58. Remodeling of retinal capillaries in the diabetic hypertensive rat.
Dosso AA; Leuenberger PM; Rungger-Brändle E
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2405-10. PubMed ID: 10476809
[TBL] [Abstract][Full Text] [Related]
59. Intervention with the aldose reductase inhibitor, tolrestat, in renal and retinal lesions of streptozotocin-diabetic rats.
McCaleb ML; McKean ML; Hohman TC; Laver N; Robison WG
Diabetologia; 1991 Oct; 34(10):695-701. PubMed ID: 1959701
[TBL] [Abstract][Full Text] [Related]
60. Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria.
Chavers BM; Bilous RW; Ellis EN; Steffes MW; Mauer SM
N Engl J Med; 1989 Apr; 320(15):966-70. PubMed ID: 2784542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
